• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    6/18/24 1:39:53 PM ET
    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Computer Software: Prepackaged Software
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ALAR alert in real time by email

    Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.

    Quantum shares dipped 44.5% to $0.43 on Tuesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Reliance Global Group, Inc. (NASDAQ:RELI) shares jumped 350% to $1.00 after the company issued an update on the pending acquisition of Spetner Associates.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) shares rose 166% to $0.3930 after jumping 30% on Monday.
    • Actelis Networks, Inc. (NASDAQ:ASNS) climbed 80.9% to $2.08 after the company announced a partnership with Carahsoft Technology Corp.
    • Comtech Telecommunications Corp. (NASDAQ:CMTL) rose 65% to $3.5801 after the company announced a new $222 million credit facility.
    • Mustang Bio, Inc. (NASDAQ:MBIO) gained 60.6% to $1.2050. Mustang Bio shares jumped 477% on Monday after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) climbed 39.2% to $0.2342 following fourth-quarter results.
    • Silk Road Medical, Inc (NASDAQ:SILK) jumped 23.8% to $26.83 after the company entered a definitive deal to be acquired by Boston Scientific for $27.50 per share.
    • Mesa Air Group, Inc. (NASDAQ:MESA) gained 23.7% to $1.3990 following upbeat quarterly earnings.
    • Silynxcom Ltd. (NASDAQ:SYNX) gained 20.4% to $3.8826 as the company secured multiple orders from the  US Federal and Law Enforcement Organizations of its new tactical system.
    • La-Z-Boy Incorporated (NYSE:LZB) jumped 17.7% to $40.11.
    • Karooooo Ltd. (NASDAQ:KARO) gained 14.6% to $33.59
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares rose 14.5% to $0.2049 following better-than-expected fourth-quarter earnings.
    • Chegg, Inc. (NYSE:CHGG) rose 14.2% to $2.9811 after the company announced a restructuring plan and new vision for growth.
    • Mynd.ai, Inc. (NASDAQ:MYND) gained 9.7% to $2.7183.
    • Patterson Companies, Inc. (NASDAQ:PDCO) gained 9.7% to $25.06 following quarterly results.
    • Chewy, Inc. (NYSE:CHWY) climbed 9.4% to $24.96
    • Rocket Lab USA, Inc. (NASDAQ:RKLB) rose 9% to $4.7305 after signing a 10-launch deal with Japanese firm Synspective in Tokyo.
    • Toast, Inc. (NYSE:TOST) gained 8.7% to $24.57.
    • e.l.f. Beauty, Inc. (NYSE:ELF) rose 7% to $209.00 after Canaccord Genuity maintained a Buy rating and raised its price target from $214 to $250.

    Losers

    • Solidion Technology Inc. (NASDAQ:STI) shares fell 68.4% to $0.6078.
    • DermTech, Inc. (NASDAQ:DMTK) fell 58.4% to $0.1383 after the company filed for Chapter 11 protection and implemented a 20% workforce reduction to preserve cash.
    • Interactive Strength Inc. (NASDAQ:TRNR) shares fell 38.9% to $3.00 after surging 71% on Monday.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) shares fell 37% to $2.10. Aerwins Technologies named Kiran Sidhu as the company's interim CFO, following resignation of Yinshun He as CFO on June 11. On June 14, the company received final delisting notice from Nasdaq Hearings Panel of Nasdaq Stock Market.
    • Taysha Gene Therapies Inc (NASDAQ:TSHA) shares fell 34.5% to $2.64 after the company announced longer-term clinical data from the ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from the REVEAL Phase 1/2 pediatric trial of TSHA-102 in Rett syndrome.
    • Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) dipped 32.7% to $5.64 after the FDA placed a partial clinical hold on ZN-c3-001, DENALI, and TETON monotherapy studies of Azenosertib following two recent deaths due to presumed sepsis in the DENALI study.
    • Kaival Brands Innovations Group Inc (NASDAQ:KAVL) declined 29% to $2.97
    • Scinai Immunotherapeutics Ltd (NASDAQ:SCNI) shares fell 28.6% to $4.00 after gaining 60% on Monday.
    • Alarum Technologies Ltd – ADR (NASDAQ:ALAR) fell 27.3% to $25.11.
    • Azitra Inc (NYSE:AZTR) dipped 26.2% to $0.16.
    • Autonomix Medical Inc (NASDAQ:AMIX) shares declined 26% to $1.02 as the company announced preliminary results from first five patients in PoC trial for pancreatic cancer pain.
    • Haoxi Health Technology Ltd (NASDAQ:HAO) dipped 19.4% to $4.62.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares declined 18.6% to $0.62 after jumping over 10% on Monday.
    • Cabaletta Bio Inc (NASDAQ:CABA) shares fell 15.3% to $7.93.
    • Neurogene Inc (NASDAQ:NGNE) dipped 15.3% to $33.88. The company announced that the first patient in Cohort 2 received high-dose NGN-401 gene therapy in the Phase 1/2 trial for female pediatric patients with Rett syndrome.
    • Polestar Automotive Holding Uk Plc (NASDAQ:PSNY) fell 15% to $0.72. Polestar Automotive recently announced geographic expansion and plans to enter seven new markets during 2025.
    • Earlyworks Co Ltd – ADR (NASDAQ:ELWS) shares declined 13% to $1.70. Earlyworks regained compliance with Nasdaq Minimum Bid Price Requirement.
    • SRIVARU Holding Limited (NASDAQ:SVMH) shares fell 12.3% to $0.21.
    • Skye Bioscience Inc (NASDAQ:SKYE) dipped 12.3% to $9.52. Cantor Fitzgerald analyst Kristen Kluska reiterated Skye Bioscience with an Overweight and maintained a $14 price target.
    • CureVac BV (NASDAQ:CVAC) declined 9.4% to $3.15.
    • Novavax Inc (NASDAQ:NVAX) fell 6.2% to $13.18.
    • Geron Corp (NASDAQ:GERN) declined 5.4% to $4.42.

    Now Read This: Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday

    Get the next $ALAR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALAR
    $AMIX
    $ASNS
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Toast Inc.
    $TOST
    4/22/2026$35.00Outperform
    BMO Capital Markets
    Rocket Lab Corporation
    $RKLB
    4/7/2026$85.00Mkt Perform → Mkt Outperform
    Citizens
    e.l.f. Beauty Inc.
    $ELF
    4/3/2026$68.00In-line
    Evercore ISI
    e.l.f. Beauty Inc.
    $ELF
    4/2/2026$68.00In-line
    Evercore ISI
    Rocket Lab Corporation
    $RKLB
    4/1/2026$60.00Equal Weight
    Wells Fargo
    Toast Inc.
    $TOST
    3/31/2026$26.00Hold
    Loop Capital
    Quantum Corporation
    $QMCO
    3/25/2026$8.00Buy
    Lake Street
    Zentalis Pharmaceuticals Inc.
    $ZNTL
    3/17/2026$5.00Equal Weight
    Wells Fargo
    More analyst ratings

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    SEC Filings

    View All

    SEC Form DEF 14A filed by Interactive Strength Inc.

    DEF 14A - Interactive Strength, Inc. (0001785056) (Filer)

    4/24/26 4:01:55 PM ET
    $TRNR
    Consumer Electronics/Appliances
    Technology

    Actelis Networks Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ACTELIS NETWORKS INC (0001141284) (Filer)

    4/24/26 2:24:35 PM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    SEC Form EFFECT filed by Sonoma Pharmaceuticals Inc.

    EFFECT - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer)

    4/24/26 12:15:24 AM ET
    $SNOA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Farrell Matthew bought $464,814 worth of shares (5,000 units at $92.96), increasing direct ownership by 86% to 10,820 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/23/26 4:07:34 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    PRESIDENT, CEO, EXEC CHAIRMAN Rosensweig Daniel bought $56,360 worth of shares (100,000 units at $0.56), increasing direct ownership by 1% to 7,625,075 units (SEC Form 4)

    4 - CHEGG, INC (0001364954) (Issuer)

    2/18/26 6:30:27 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Actelis Networks Commences Trading on the OTCQB Venture Market

    SUNNYVALE, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (OTCQB:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced that its common stock has commenced trading on the OTCQB Venture Market operated by OTC Markets Group, effective at the open of business on April 24, 2026. The Company's common stock continues to trade under the symbol "ASNS." The transition to OTCQB follows the Company's previously announced move from The Nasdaq Capital Market to the OTC Markets, and the Company's application to the OTCQB Venture Market. OTCQB is a marketplace designed for devel

    4/24/26 10:27:19 AM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

    Financing led by institutional life sciences investor, with participation from new and existing investorsCapital expected to support expansion of CDMO platform and advancement of customer programsJERUSALEM, April 24, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI), ("Scinai" or the "Company") a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics and the owner of Scinai Biopharma Services Ltd., a contract development and manufacturing organization (CDMO), today announced that it has entered into a securities purchase agreement with an institutional life sciences investor, as well as with new and existing institutional and acc

    4/24/26 8:00:00 AM ET
    $SCNI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Rocket Lab Unveils New High-Performance Star Tracker Optimized for Accuracy in Increased Radiation Environments

    LONG BEACH, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced its next-generation High-Performance Star Tracker (ST-HP), designed to improve key performance metrics for longer duration spacecraft missions in low Earth orbit and beyond. The High-Performance Star Tracker combines enhanced resilience with a targeted pointing accuracy of better than 1 arcsecond, ideal for missions where radiation tolerance is critical. The ST-HP's greater than 50 kRad, board-level Total Irradiation Dose ensures sustained attitude determination performance, maintaining precise sp

    4/23/26 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Commercial Officer Dicken Scott Fraser converted options into 1,764 units of Class A American Depositary Shares and was granted 92 units of Class A American Depositary Shares (SEC Form 4)

    4 - Polestar Automotive Holding UK PLC (0001884082) (Issuer)

    4/23/26 5:17:02 PM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Chief Digital Officer Simonsson Beatrice Ingmarie converted options into 953 units of Class A American Depositary Shares, increasing direct ownership by 512% to 1,139 units (SEC Form 4)

    4 - Polestar Automotive Holding UK PLC (0001884082) (Issuer)

    4/23/26 5:14:48 PM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Chief Operating Officer Engstrom Jonas Hakan converted options into 2,028 units of Class A American Depositary Shares and was granted 231 units of Class A American Depositary Shares, increasing direct ownership by 150% to 3,768 units (SEC Form 4)

    4 - Polestar Automotive Holding UK PLC (0001884082) (Issuer)

    4/23/26 5:12:29 PM ET
    $PSNY
    Auto Manufacturing
    Industrials

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Toast with a new price target

    BMO Capital Markets initiated coverage of Toast with a rating of Outperform and set a new price target of $35.00

    4/22/26 7:58:13 AM ET
    $TOST
    EDP Services
    Technology

    Rocket Lab USA upgraded by Citizens with a new price target

    Citizens upgraded Rocket Lab USA from Mkt Perform to Mkt Outperform and set a new price target of $85.00

    4/7/26 8:36:34 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Evercore ISI initiated coverage on e.l.f. Beauty with a new price target

    Evercore ISI initiated coverage of e.l.f. Beauty with a rating of In-line and set a new price target of $68.00

    4/3/26 10:44:59 AM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors

    Ms. Shafer, a proven commercial leader in rare neurological diseases, will lead Neurogene's commercial strategy and launch readiness for NGN-401 gene therapy for Rett syndrome Ms. Mikail, President and CFO of Neurogene, adds strategic and operational leadership to the Board as Company advances key priorities Neurogene Inc. (NASDAQ:NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the appointment of Christy Shafer as Chief Commercial Officer and the appointment of Christine Mikail, J.D., to its Board of Directors. Ms. Shafer brings more than 20 years of industry experience buil

    4/20/26 7:30:00 AM ET
    $NGNE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary

    FOSTER CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary. "Tim has deep expertise in the biopharmaceutical industry and a proven track record of leading the legal function at commercial-stage organizations," said Harout Semerjian, President and Chief Executive Officer of Geron. "The addition of Tim, coupled with our recent Board appointments, further strengthens our leadership team. His strategic counsel will be invaluable as we

    4/13/26 8:00:00 AM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

    Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline  GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi

    3/30/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by Neurogene Inc.

    SC 13G - Neurogene Inc. (0001404644) (Subject)

    12/11/24 4:05:09 PM ET
    $NGNE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Financials

    Live finance-specific insights

    View All

    Toast Announces Release Date Of First Quarter 2026 Financial Results

    Toast (NYSE:TOST), the all-in-one digital technology platform built for hospitality, will release financial results for the first quarter ended March 31, 2026 following the close of the U.S. markets on Thursday, May 7, 2026. Toast will host a conference call to discuss its results at 5:00 p.m. Eastern Time the same day. The news release with financial results and a link to the conference call will be accessible at the Toast investor relations website: https://investors.toasttab.com. A replay of the conference call will also be available on Toast's investor relations website. About Toast Toast (NYSE:TOST) is a cloud-based, all-in-one digital technology platform purpose-built for the en

    4/23/26 4:05:00 PM ET
    $TOST
    EDP Services
    Technology

    Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026

    FOSTER CITY, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that it will release its first quarter 2026 financial results and business highlights before the market opens on Wednesday, May 6, 2026 via press release, which will be available on the Investors and Media section of the Company's website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time. A live and archived audio webcast of the conference call will be available from the Investors and Media section of the Company's website at www.geron.com. About GeronGero

    4/22/26 7:00:00 AM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    La-Z-Boy Incorporated Announces Sale of American Drew and Kincaid Wholesale Casegoods Businesses

    Key Highlights: American Drew and Kincaid wholesale casegoods businesses to be sold to Banner House (formerly Magnussen Home Furnishings, Inc.), a multi-branded portfolio of home furnitureTransaction is scheduled to close in mid-MayLa-Z-Boy will continue to offer casegoods products in its 374 stores across North America as part of its whole home solution for consumersSeamless transition expected for existing customers, dealers, and suppliersTransaction advances La-Z-Boy Incorporated progress of focusing on its core, vertically integrated North American upholstery business MONROE, Mich., April 21, 2026 (GLOBE NEWSWIRE) -- La-Z-Boy Incorporated (NYSE:LZB), a global leader in the retail and

    4/21/26 4:15:00 PM ET
    $LZB
    Home Furnishings
    Consumer Discretionary